Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Connaught

Executive Summary

Awarded one-year federal supply contract for Tripedia DTP vaccine by the Centers for Disease Control and Prevention. Approved in August ("The Pink Sheet" Aug. 31, p. 6), Tripedia is the first acellular diphtheria and tetanus toxoids and acellular pertussis vaccine (DTP) vaccine purchased by the government for distribution to state and territorial health departments for public immunization programs. Tripedia is given as the fourth and fifth doses in the five-dose DTP series. Under the terms of the contract, Connaught will charge CDC $6.45 per dose, plus an excise tax of $4.50. The quantity supplied to government programs may range from 350,000 to 3.5 mil. doses. Connaught also has CDC contract for whole-cell pertussis DTP vaccine.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021732

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel